Displaying items by tag: school of public health
UAB Heersink School of Medicine has awarded three grants for the latest annual Multi-Investigator Program Award cycle. The 2022/2023 AMC21 Multi-PI Awards, which provide grant funding of $150,000 per year for two years, were awarded to Javier Neyra, M.D., Carlos Orihuela, Ph.D., and Anna Thalacker-Mercer, Ph.D.
Tagged under
- department of medicine
- division of nephrology
- department of microbiology
- department of cell, developmental and integrative biology
- division of pulmonary, allergy and critical care medicine
- division of infectious diseases
- school of public health
- department of epidemiology
- department of anesthesiology and perioperative medicine
- department of emergency medicine
- division of cardiovascular disease
- division of pediatric neurology
- department of neurology
- department of anesthesiology
In a collaborative study using a mouse model, University of Alabama at Birmingham researchers from the departments of Anesthesiology and Perioperative Medicine, Biostatistics, Emergency Medicine, Pathology, and Surgery have found mechanistic links between older stored red blood cell transfusions and subsequent bacterial pneumonia.
Tagged under
The biomarker, the protein kinase LRRK2, is a promising candidate for future exploration.
Tagged under
Several UAB programs ranked among the nation’s top 20 in 2017 edition of U.S. News & World Report’s “Best Graduate Schools."
Tagged under
The Birmingham Business Journal’s award recognizes UAB’s next generation of leaders for their efforts in health care policy and strategic planning.
UAB’s Community Engagement Institute brings academic researchers and community leaders together to brainstorm ways to improve Birmingham, the region and the world.
Tagged under
UAB is leading a team of researchers in a trial to combat blood pressure risk factors.
Tagged under
An interdisciplinary effort among the College of Arts and Sciences and several schools across campus results in a $2.5 million grant.
Tagged under
A series of fascinating studies at Harvard University showed that many people respond positively to placebo pills — even when they are told that the pills don't have any active ingredients. Now researchers at UAB have partnered with a Harvard scientist to test these "open-label" placebos for the first time in cancer survivors.
Tagged under
This improvement in cognition persists despite a high-glycemic-index diet, a possible risk factor for Alzheimer’s.
Tagged under